Short-Term Outcome of Patients with Cirrhosis and Concurrent Portal Cavernoma Presenting with Acute Variceal Bleeding

Table 2

Summary of efficacy measurements during the 5-day period.

	The cavernoma group	The control group	value
5-day treatment failure, (%)	9 (32.1%)	7 (12.5%)	0.031
Failure to control acute bleeding, (%)	5 (17.9%)	3 (5.4%)	0.066
Early rebleeding in 5 days, (%)	4 (14.3%)	2 (3.6%)	0.072
5-day mortality, (%)	3 (10.7%)	2 (3.6%)	0.192